BioSpace News Archive

ARIKAYCE Preliminary U.S. Net Product Sales Approximately $21.0 Million for the First Quarter of 2019

Metrion Biosciences, the specialist ion channel contract research and drug discovery company, announced the appointment of Dr Andrew Southan as Chief Executive Officer, with immediate effect.

Check-Cap Ltd. today announced the initiation of its U.S. pilot study of the C-Scan® system, following Institutional Review Board approval and full Investigational Device Exemption application approval by the U.S. Food and Drug Administration.

Company Will Host Conference Call at 5:00 p.m. on Monday, April 8, 2019

Antengene Corporation, a clinical stage biopharmaceutical company specializing in the development of oncology and anti-viral therapeutics, today announced the establishment of its U.S. subsidiary and plans for collaborations with the Baruch S. Blumberg Institute, which resides in the Pennsylvania Biotechnology Center where the Antengene U.S. subsidiary is located.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) will release its first-quarter 2019 financial results on Monday, May 6, 2019. Bausch Health will host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide a business update.

Patent claims RSV fusion protein inhibitors as medicines including lead pipeline candidate, RV521; patent nominally expires in 2035 (unextended)

Novel DNA Manufacturing Platform Seeks to Pioneer New Generation of Faster, More Affordable Cell-based Therapeutics for Patients

- Wolverine Human Services (WHS), Michigan’s largest child welfare agency, has partnered with Salesforce to create Noble Child, the first cloud-based IT system to meet the data tracking needs of the entire child welfare industry.

EMD Serono, Inc. today announced that Express Scripts is covering on its formulary the oral multiple sclerosis (MS) therapy, MAVENCLAD® (cladribine) tablets, which was approved by the U.S. Food and Drug Administration (FDA) on March 29, 2019.